Why the study?
Does LCZ696 attenuate cardiac remodeling and dysfunction after myocardial infarction compared to stand-alone neprilysin inhibitor or angiotensin receptor blocker?
Does LCZ696 attenuate cardiac remodeling and dysfunction after myocardial infarction compared to stand-alone neprilysin inhibitor or angiotensin receptor blocker?
LCZ696 provides superior attenuation of cardiac remodeling, fibrosis, and hypertrophy post-MI compared to ARB or neprilysin inhibitor alone.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for LCZ696 post-MI; leaves open translation of superior remodeling effects to human trials.
LCZ696 attenuated cardiac remodeling and dysfunction after MI. This may be contributed to by superior inhibition of LCZ696 on cardiac fibrosis and cardiac hypertrophy than either stand-alone neprilysin inhibitor or angiotensin receptor blocker.
No takes yet. Share an insight, caveat, or question.
Lueder et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: